Results 91 to 100 of about 3,186 (203)
24-week real world outcomes of nemolizumab in patients with prurigo nodularis
Journal of Dermatological TreatmentBackgrounds Prurigo nodularis (PN) is a chronic pruritic inflammatory disease associated with immune and neural dysregulation. Although nemolizumab has demonstrated efficacy in clinical trials, real-world post-marketing data remain limited.Objective To ...
Yoshihito Mima +2 more
doaj +1 more source
Effectiveness of Narrowband Ultraviolet B Therapy in Prurigo Nodularis: A Retrospective Cohort Study from a Tertiary Care Center [PDF]
Burhan Engіn +2 more
openalex +1 more source
MRGPRX2-Mediated Mast Cell Activation is a Shared Pathogenic Mechanism in Atopic Dermatitis and Prurigo Nodularis Patients that can be Therapeutically Targeted via Siglecs [PDF]
Zachary Benet +5 more
openalex +1 more source
Prevalence of prurigo nodularis in the United States of America: A retrospective database analysis
, 2020 Sonja Ständer +6 more
openalex +1 more source
The Journal of the American Osteopathic Association, 1996 S GROVER, H SUBRAMANYA
openaire +3 more sources
Dupilumab Significantly Reduces Symptoms of Prurigo Nodularis and Depression: A Case Series
, 2022 Louise Lönndahl +3 more
openalex +2 more sources